Technical Articles

重组人il-12 r beta 1蛋白在三条成药路线里为什么都要被验证?从 p40、p19 到受体侧
Why Three Drug-Development Routes All Validate Through IL-12 R beta 1: From p40 and p19 to the Receptor Side
发布时间 2026-11-18
p40 blockers, p19-selective IL-23 inhibitors and receptor-side programs all converge on IL-12Rβ1 engagement assays. This article traces the validation chain.
View details
  • Immunity/Inflamma
  • IL-12 R beta 1
  • IL-23
  • p40
  • p19
  • drug development
  • target validation
  • UA010373
IL-2/IL-2R信号通路:免疫平衡的双重调控与靶向药物开发
IL-2/IL-2R Signaling Pathway: Dual Regulation of Immune Balance and Targeted Drug Development
发布时间 2026-01-21
Interleukin-2 is a cytokine that plays a central role in immune regulation. The realization of its biological effects depends on precise binding with the cell surface interleukin-2 receptor.
View details
  • Immunity/Inflamma
  • IL2/IL2R Kit
  • Immune balance
  • Drug development
超越平面,洞察真实:3D细胞活力检测技术
Unveiling the Dynamic Code of Life: pH-sensitive IgG IgG Labeling Reagents Max(Green)
发布时间 2025-11-13
In the traditional fields of life sciences and drug development, the vast majority of cellular experiments are conducted in two-dimensional culture dishes. However, this monolayer cell model differs significantly from the complex three-dimensional microenvironment in which cells reside within the human body, leading to a substantial gap between experimental data and actual in vivo responses. To bridge this divide, 3D cell viability assay technology has emerged, becoming a powerful tool for revolutionizing disease research, drug screening, and toxicology assessment.
View details
  • Cancer
  • Cell Viability Assay
  • Drug Development
Total 3
  • 1
Go to